In articles published by 247biopharma and Discover Pharma, Robert Cornog, Senior Director of Product Development, and Kevin Schaab, Senior Drug Development Consultant at Quotient Sciences, share their expert insights into the industry following their visit to BIO International 2025.
Robert shares updates on Philadelphia facility, which has been upgraded to handle high-potency compounds, enhancing safety and capacity.
Kevin highlights Translational Pharmaceutics® platform, which combines clinical testing with drug product manufacturing, and also Quotient Sciences expertise in first-in-human trials in both the UK and US.
Read the full articles at 247biopharma and Discover Pharma.